# CellCrine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellcrine

- Industry: Biotechnology
- Headquarters: US
- Latest round: Seed (Sep 12, 2022)
- Investors on record: 1

## About

Based in the US, CellCrine Inc. provides defined cell culture conditions for primary cells and cell lines. In September 2022, the firm raised a specific amount of seed funding from investor SOSV. As of 2022, the company is headed by its CEO Dr. Rodolfo Faudoa. And the company was co-founded by Octavio Gonzalez.

The company offers regenerative technology that improves cell growth. Additionally, it provides serum-free media supplements that are designed for each type of cell. The firm’s cell line and strict cell culture conditions enable the production of bio-activated growth-promoting factors.

## Funding rounds

- Seed, Sep 12, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed